Kezar Life Sciences Inc (KZR)
7.55
+0.01
(+0.13%)
USD |
NASDAQ |
Nov 14, 16:00
7.55
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Total Assets (Quarterly): 179.92M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 179.92M |
| March 31, 2024 | 199.13M |
| December 31, 2023 | 221.24M |
| September 30, 2023 | 249.33M |
| June 30, 2023 | 263.38M |
| March 31, 2023 | 284.18M |
| December 31, 2022 | 299.57M |
| September 30, 2022 | 304.77M |
| June 30, 2022 | 317.50M |
| March 31, 2022 | 251.87M |
| December 31, 2021 | 217.93M |
| September 30, 2021 | 130.89M |
| June 30, 2021 | 139.67M |
| March 31, 2021 | 152.34M |
| Date | Value |
|---|---|
| December 31, 2020 | 151.84M |
| September 30, 2020 | 161.21M |
| June 30, 2020 | 168.32M |
| March 31, 2020 | 134.64M |
| December 31, 2019 | 89.51M |
| September 30, 2019 | 97.52M |
| June 30, 2019 | 105.27M |
| March 31, 2019 | 113.06M |
| December 31, 2018 | 114.68M |
| September 30, 2018 | 120.27M |
| June 30, 2018 | 125.67M |
| March 31, 2018 | 54.25M |
| December 31, 2017 | 54.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
89.51M
Minimum
Dec 2019
317.50M
Maximum
Jun 2022
206.17M
Average
199.13M
Median
Mar 2024
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 29.24M |
| Shareholders Equity (Quarterly) | 150.68M |